Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer

by E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein
Published 2014-08-01

Cytofluorometric characteristics of molecular subtypes of breast cancer

by L. K. Tsoi, V. N. Bogatyrev, I. V. Vysotskaya, V. P. Letyagin, E. A. Kim
Published 2014-08-01

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories

by I. V. Vуsotskaya, V. P. Letyagin, I. K. Vorotnikov, V. U. Kirsanov, I. A. Gladilina, E. A. Kim
Published 2019-09-01

CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS

by E. A. Kim, A. M. Platova, I. V. Visotzkaya, E. S. Gershteyn, V. P. Letyagin, N. E. Kushlinskiy, E. E. Mironova
Published 2014-09-01

The clinical and morphological features and prognosis in rare breast carcinomas

by I. V. Vysotskaya, G. V. Martynova, V. P. Letyagin, V. D. Ermilova, E. M. Pogodina, E. A. Kim, K. V. Maksimov
Published 2014-08-01

Current molecular genetic markers of breast cancer

by N. V. Apanovich, V. P. Shubin, A. A. Korotayeva, A. S. Bavykin, E. A. Kim, A. D. Zakiryakhodzhayev, V. P. Letyagin, I. V. Vysotskaya, A. V. Karpukhin
Published 2014-07-01